摘要
目的探讨术前门静脉栓塞(portal vein embolization,PVE)在Ⅳ型肝门胆管癌中的应用价值。方法对2010年12月至2011年2月中国医科大学附属盛京医院肝胆脾外科术前行PVE的2例Ⅳ型肝门胆管癌进行分析。结果 2例均行经皮经肝胆道引流(percutaneous transhepatic biliary drainage,PTBD)解除梗阻性黄疸,PVE诱导剩余肝体积代偿增生后,未来剩余肝(future liver remnant,FLR)与全肝体积(total liver volume,TLV)之比分别为49.7%、43.7%,较PVE前分别增加7.9%,5.4%。2例行右半肝及尾状叶切除、肝门胆管癌根治术,手术顺利,术后恢复良好,至今分别无瘤生存18、19个月。结论 PVE能够安全有效增加FLR,从而增加手术安全性,降低术后肝衰竭的发生率。
Objective To explore the application value of preoperative portal vein embolization （PVE） for type 1V hilar cholangiocarcinoma. Methods The data of 2 cases of type IV hilar eholangiocarcinoma performed preoperative PVE between December 2010 and February 2011 in Department of Hepatobiliary and Splenic Surgery, Shengjing Hospital of China Medical University were analyzed. Results Two cases were performed percutaneous transhepatic biliary drainage （PTBD） to release the obstructive jaundice. After PVE was performed to induce liver remnant compengatory hyperplasia, future liver remnant/total liver volume （FLR/TLV） was 49.7%, 43.7%1 and increased 7.9%, 5.4%, respectively. Then right liver and caudate lobe resection, hilar cholangiocarcinoma radical resection were performed. Patients got good recovery with disease-free survival 18, 19 months. Conclusion PVE is considered safe and effective to increase FLR, increase the safety of the operation and reduce the incidence of postoperative liver failure.
出处
《中国实用外科杂志》
CSCD
北大核心
2012年第11期924-924,925-927,共4页
Chinese Journal of Practical Surgery
关键词
门静脉栓塞
肝门胆管癌
半肝切除术
portal vein embolization
hilar cholangiocarcinoma
hemihepatectomy
